Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain

Recruiting

Phase 1

Phase 2

Hemp-Derived CBDAssessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain

Sponsor:

Staci Gruber, Ph.D.

Code:

NCT07728695

Conditions

Endometriosis

Adenomyosis

Chronic Pelvic Inflammatory Disease

Eligibility Criteria

Sex: Female

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Custom-formulated, high-CBD study product

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-01. This information was provided to ClinicalTrials.gov by Staci Gruber, Ph.D. on 2026-07-27.